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IDS Control in China
. Shao
Chinese Center for Disease Control and Prevention (China
DC), Beijing, China
IV/AIDS were ﬁrst detected in China in the mid 1980s
mong foreign travelers and hemophilia patients. The epi-
emics started among IDUs in southwest China in the late
980s. The 2nd wave of the epidemic was in the paid plasma
onors in central China in the mid 1990s. While the IDU epi-
emic keeps at a high but relatively stable level, sexual
ransmitted HIV cases in both CSW and MSM have increased
apidly in recent years. In 2007, sexual transmission has
ecome the largest portion of newly reported HIV infection
or the ﬁrst time. All signs indicate that the HIV epidemic in
hina is at a turning point, spreading from high risk groups
o the general population. By the end of 2007, the esti-
ated number of HIV infected people in China was 700,000.
n order to control AIDS, China has launched an impressive
IDS campaign, called Four Free One Care (free VCT, ART,
MTCT and education for AIDS affected children, living assis-
ants to AIDS family). More high risk population has been
ested and the positive ones have received various interven-
ion package, including condom, methadone substitutions
nd needle exchange programs. More than 40,000 patients
ave been experienced triple drugs therapy and thousands of
ives have been saved. Even though progress has been made,
hallenges remain at both societal and technical levels. The
apid increasing STI cases indicate further spread of HIV in
he future. Due to drug toxicity and HIV resistance, over
0% of patients have stopped treatment. Additional effort
nd strategy are needed to further increasing prevention
overage in both high risk groups and general population.
nly with enhancing scientiﬁc research and evidence-based
trategy, can China seize the opportunity to stop AIDS at the
ritical time in China’s AIDS control history. International
ollaboration between scientists, NGOs and governmental
gencies will help China reaching her AIDS control goal ear-
ier and better.
oi:10.1016/j.ijid.2008.05.114
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IDS in Malaysia
. Kamarulzaman
University of Malaya, Kuala Lumpur, Malaysia
ike many countries in the region, Malaysia’s HIV epi-
emic has been predominantly driven by injecting drug use
lthough latterly heterosexual transmission and transmis-
ion amongst MSM have been on the rise. The estimated
dult prevalence of HIV infection is 0.4% with the last few
ears seeing a signiﬁcant trend in the percentage of women
ecoming infected with women and girls making up almost
5% of newly reported HIV infections nationwide by the end
f 2006. The estimated HIV prevalence amongst injecting
rug users who are predominantly male range from 16—40%
ith continuing high rates of needle sharing and low usage
f condom during sexual interactions.
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Scaling up HIV prevention in Malaysia remains a sig-
iﬁcant challenge due to the existence of legislative and
ocio-cultural barriers. Nonetheless in recent years, harm
eduction programs have become possible including the
iloting of methadone maintenance and needle exchange
rograms. Efforts at scaling up both these programs nation-
ide are currently underway.
On the treatment front, Malaysia took the bold step of
ssuing compulsory licensing in 2001 and together with direct
egotiation with pharmaceutical companies saw a marked
ecrease in the cost of many antiretroviral agents. This
nabled free access to ﬁrst line HAART therapy to those
nfected since. Nevertheless a large proportion of those eli-
ible to treatment remain untreated due to various factors
ncluding poorer access in rural areas and the pervasive
tigma and discrimination that prevents many from coming
orward for medical care.
In conclusion, although signiﬁcant progress has been
ade in the country’s response to HIV/AIDS, scaling up pre-
ention, treatment and care to meet Universal Access goals
emain a challenge in this country.
oi:10.1016/j.ijid.2008.05.115
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ntimicrobial Practices and Resistance in Pediatrics in an
IV Endemic Area of Cambodia
. Benca ∗, L. Seng Duong
House of Hope, Phnom Penh, Cambodia
ackground: Major health problems of Cambodia include TB
ith 400-600 new cases per 100000/year, HIV/AIDS and Pl.
alciparum resistant malaria. Concerning antibiotic policy,
inistry of Health guidelines exist and also WHO/UN/CDC
uidelines are adopted in the clinical practice. The num-
er of physicians is low due to genocide 25 years ago
hen 1,8million of inhabitants and virtually all doctors,
urses and health care workers were executed. All antibiotic
lasses are available in the market, 90% of them generic,
owever with good quality, manufactured in Thailand and
ndia and containing 85—100% of the original substances.
ntiretrovirals, but not antibiotics, antituberculotics and
ntimalarials are available for free from the government or
GO’s.
Methods: Study participants were HIV positive Cambo-
ian children treated with HAART (stavudine, lamivudine
nd nevirapine or efavirenz). We assessed antibiotic resis-
ance rates in respiratory tract isolates (nose, pharyngeal,
ar swabs) from 93 Cambodian previously ART naive chil-
ren.
Results: Antibiotic resistance rates investigated in 93
ambodian HIV infected children in 2007 were extremely
igh, including ESBL and Ciproﬂoxacine resistance in Enter-
bacteriaceae spp. up to 100% and MRSA up to 80% with
iphasis tendency and sustained decrease of resistance with
he increase of the population receiving HAART.
Conclusion: Reversibility of resistance among isolates
rom respiratory system was probably due to the reconstitu-
